GlassScriptPhysician profile
Jyl Curry
NPI 1275954521
$4,459.84
in general payments reported to CMS, 2019-2025
18 companies · $849 in 2025
The $849 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $942 · 2022: $932 · 2023: $896 · 2024: $841 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,585.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,066.45 | 2021-2025 | Airsupra, Breztri |
| Inari Medical, INC. | $523.92 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $358.35 | 2023-2024 | Freestyle Libre 3 |
| Abbvie INC. | $354.36 | 2021-2025 | |
| Lilly USA, LLC | $288.65 | 2022-2025 | Mounjaro |
| Biohaven Pharmaceuticals, INC. | $249.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.59 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $226.67 | 2021-2022 | |
| Pulmonx Corporation | $147.06 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Corium, LLC | $125.86 | 2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $121.91 | 2023 | |
| Sanofi-Aventis U.S. LLC | $121.83 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.25 | 2024 | Xifaxan |
| Pharmacosmos Therapeutics INC. | $115.24 | 2023 | Monoferric |
| Pfizer INC. | $111.79 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $108.73 | 2023 | Xarelto |
| Amgen INC. | $97.10 | 2021 | |
| Glaxosmithkline, LLC. | $96.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyl Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.